Comparison of three alternatives for the management of moderate asthma in children aged 6–11 years: a cost-utility analysis

References

• Ferrante G, Grutta LS. The burden of pediatric asthma. Front Pediatr 2018;6:186.
   PubMed Web of Science ®Google Scholar
• Fischer GB, Sarria EE, Camargos P, Mocelin HT, Soto-Quiroz M, Cruz AA, Bousquet J, Zar HJ. Childhood asthma in low and middle-income countries: where are we now? Paediatr Respir Rev 2019;31:52–57. doi:10.1016/j.prrv.2018.10.002.
   PubMed Web of Science ®Google Scholar
• Ferreira de Magalhães M, Amaral R, Pereira AM, Sá-Sousa A, Azevedo I, Azevedo LF, Fonseca JA. Cost of asthma in children: a nationwide, population-based, cost-of-illness study. Pediatr Allergy Immunol 2017;28(7):683–691. doi:10.1111/pai.12772.
   PubMed Web of Science ®Google Scholar
• Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA. Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country. Allergol Immunopathol (Madr) 2020;48(2):142–148. doi:10.1016/j.aller.2019.06.015.
   PubMed Web of Science ®Google Scholar
• Buendia JA, Acuna-Cordero R, Rodriguez-Martinez CE. The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children. Pediatr Pulmonol 2020;55(10):2610–2616. doi:10.1002/ppul.25024.
   PubMed Web of Science ®Google Scholar
• Buendia JA, Acuna-Cordero R, Rodriguez-Martinez CE. Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Eff Resour Alloc 2021;19(1):33. doi:10.1186/s12962-021-00287-3.
   PubMed Web of Science ®Google Scholar
• Buendia JA, Rodriguez-Martinez CE, Sossa-Briceno MP. Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years. Pediatr Allergy Immunol. 2021;32(8):1866–1868.
   PubMedGoogle Scholar
• Jefferson Antonio B, Ranniery AC, Carlos ER. [Predictors of hospitalization plus airway support among infants with recurrent wheezing in the emergency department]. Zhongguo Dang Dai Er Ke Za Zhi 2021;23(5):438–444.
   PubMedGoogle Scholar
• Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, et al. Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020;146(6):1217–1270. doi:10.1016/j.jaci.2020.10.003.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006;130(6):1733–1743. doi:10.1378/chest.130.6.1733.
   PubMed Web of Science ®Google Scholar
• Adams NP, Jones PW. The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. Respir Med 2006;100(8):1297–1306. doi:10.1016/j.rmed.2006.04.015.
   PubMed Web of Science ®Google Scholar
• Asthma GIf. Global Strategy for Ashtma Management and Prevention, 2021. Available from: https://ginasthma.org/ [last accessed 06 May 2021].
   Google Scholar
• Vaessen-Verberne AAPH, van den Berg NJ, van Nierop JC, Brackel HJL, Gerrits GPJM, Hop WCJ, Duiverman EJ. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. Am J Respir Crit Care Med 2010;182(10):1221–1227. doi:10.1164/rccm.201002-0193OC.
   PubMed Web of Science ®Google Scholar
• Buendia JA, Patino DG. Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma. BMC Pulm Med 2021;21(1):398.
   PubMed Web of Science ®Google Scholar
• Dennis R, Caraballo L, García E, Caballero A, Aristizabal G, Córdoba H, Rodriguez MN, Rojas MX, Orduz C, Cardona R, et al. Asthma and other allergic conditions in Colombia: a study in 6 cities. Ann Allergy Asthma Immunol 2004;93(6):568–574. doi:10.1016/S1081-1206(10)61265-3.
   PubMedGoogle Scholar
• Espinosa O, Rodriguez-Lesmes P, Orozco E, Avila D, Enriquez H, Romano G, Ceballos M. Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from colombia. Health Policy Plan 2022;37(3):359–368.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma. J Asthma 2013;50(4):410–418. doi:10.3109/02770903.2013.767909.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, et al. CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health 2022;25(1):3–9. doi:10.1016/j.jval.2021.11.1351.
   PubMed Web of Science ®Google Scholar
• Crossingham I, Turner S, Ramakrishnan S, Fries A, Gowell M, Yasmin F, Richardson R, Webb P, O’Boyle E, Hinks TS. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev 2021;5:CD013518.
   PubMedGoogle Scholar
• Estadística DANd. Archivo Nacional de Datos Bogota. Colombia: DANE; 2021. Available from: www.dane.gov.co.
   Google Scholar
• Consortium YHE. Net Monetary Benefit [online] 2016. Available from: https://yhec.co.uk/glossary/net-monetary-benefit/ [last accessed 07 July 2022].
   Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP, Nino G. Budesonide/formoterol as maintenance and reliever therapy compared to fixed-budesonide/formoterol plus albuterol reliever for pediatric asthma: a cost-utility analysis in Colombia. J Allergy Clin Immunol Pract. 2021;9(10):3816–3818.
   PubMedGoogle Scholar
• Reddel HK, O’Byrne PM, FitzGerald JM, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Puu M, Alagappan VKT, Bateman ED. Efficacy and safety of as-needed budesonide-formoterol in adolescents with mild asthma. J Allergy Clin Immunol Pract 2021;9(8):3069–3077.e6.
   PubMed Web of Science ®Google Scholar
• Hatter L, Bruce P, Braithwaite I, Holliday M, Fingleton J, Weatherall M, Beasley R. ICS-formoterol reliever versus ICS and short-acting beta2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Res 2021;7(1):00701-2020. doi:10.1183/23120541.00701-2020.
   PubMedGoogle Scholar
• Nalin U, Stout S, Portnoy JM. Single inhaler maintenance and reliever therapy in pediatric asthma. Curr Opin Allergy Clin Immunol 2019;19(2):111–117. doi:10.1097/ACI.0000000000000518.
   PubMed Web of Science ®Google Scholar
• Peters SP, Prenner BM, Mezzanotte WS, Martin P, O’Brien CD. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc 2008;29(5):499–516. doi:10.2500/aap.2008.29.3147.
   PubMed Web of Science ®Google Scholar
• Loymans RJB, Gemperli A, Cohen J, Rubinstein SM, Sterk PJ, Reddel HK, Jüni P, ter Riet G. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis. BMJ 2014;348:g3009. doi:10.1136/bmj.g3009.
   PubMed Web of Science ®Google Scholar
• Trojanowska A, Emeryk A, Zarzycka D. Adherence to therapy regimen by children with asthma and their parents. Postepy Dermatol Alergol 2022;39(2):258–264. doi:10.5114/ada.2022.115886.
   PubMedGoogle Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP. Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy? J Asthma. 2022;59(7):1360–1371.
   PubMedGoogle Scholar
• DiSantostefano RL, Boudiaf N, Stempel DA, Barnes NC, Greening AP. The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis. NPJ Prim Care Respir Med 2016;26:16038.
   PubMed Web of Science ®Google Scholar
• Parody-Rua E, Rubio-Valera M, Guevara-Cuellar C, Gomez-Lumbreras A, Casajuana-Closas M, Carbonell-Duacastella C, Aznar-Lou I. Economic evaluations informed exclusively by real world data: a systematic review. Int J Environ Res Public Health. 2020;17(4):1171.
   PubMedGoogle Scholar